SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Evan Dimmer who wrote (3296)12/10/1997 4:59:00 PM
From: raymond marcotte  Read Replies (1) of 23519
 
evan, sometimes the most difficult thing to do in this life is to just sit on your hands. $20 is much better than $40. but there are times when you can't afford to hold on! this may be one of them.

the press release is fatal.

"A study of 123 impotent men treated with Vivus' Muse product at the Centre for Impotence and Fertility in Rome, Italy found
that Muse failed to make 121 of the penises rigid. This test's endpoint was very different than Vivus' 1996 study, which used an
''Erection Assessment Scale.'' The Italian study actually measured the rigidity of each penis and concluded that the penises
were not hard."

surely this is a tough one to get caught up in, but you are better off taking you medicine now. sell on any recovery and invest the balance in something with more solid prospects - like merck, lily, or pfizer. the landscape is littered with companies that never recovered from such a turn of events.

we all have had our disasters and incredible misfortunes. it may be good to avoid denial and deal with yours straight on. get proactive and prepare to move on with a good lesson under your belt. the guys that were in at $40 in early october and still waiting will be suffering for a long, long time.

ray
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News